Weekly GLP-1 receptor agonist pens for subcutaneous delivery in type 2 diabetes therapy. Integrated into treatment protocols in cardiology, endocrinology, and primary care environments by specialists. Purchased by healthcare organizations from biopharmaceutical firms through authorized wholesalers and pharmacy networks.